BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15573183)

  • 21. Local lymph node involvement in pediatric renal cell carcinoma: a report from the Italian TREP project.
    Indolfi P; Bisogno G; Cecchetto G; Spreafico F; De Salvo GL; Collini P; Jenkner A; Inserra A; Schiavetti A; di Martino M; Casale F
    Pediatr Blood Cancer; 2008 Oct; 51(4):475-8. PubMed ID: 18561180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Surgical treatment of perplexing renal cell carcinoma].
    Lin Z; Chen S; Ye C
    Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):463-4. PubMed ID: 10920947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sporadic renal cell carcinoma in young and elderly patients: are there different clinicopathological features and disease specific survival rates?
    Denzinger S; Otto W; Burger M; Hammerschmied C; Junker K; Hartmann A; Wieland WF; Walter B
    World J Surg Oncol; 2007 Feb; 5():16. PubMed ID: 17280613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal cell carcinoma lung metastases surgery: pathologic findings and prognostic factors.
    Assouad J; Petkova B; Berna P; Dujon A; Foucault C; Riquet M
    Ann Thorac Surg; 2007 Oct; 84(4):1114-20. PubMed ID: 17888956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
    Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Renal cell carcinoma with regional lymph node metastasis].
    Kitamura Y; Watanabe M; Komatsubara S; Sakata Y
    Hinyokika Kiyo; 1995 Jun; 41(6):433-8. PubMed ID: 7645451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Late results of the complex treatment of primary kidney neoplasm in children].
    Minkov N; Christosova I; Kiourktchieva S; Rousseva T
    Ann Urol (Paris); 1997; 31(6-7):344-7. PubMed ID: 9509234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma.
    Mian BM; Bhadkamkar N; Slaton JW; Pisters PW; Daliani D; Swanson DA; Pisters LL
    J Urol; 2002 Jan; 167(1):65-70. PubMed ID: 11743277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of primary-tumor extension, stage and grade of nuclear differentiation in patients with renal cell carcinoma.
    Fiori E; De Cesare A; Galati G; Bononi M; D'Andrea N; Barbarosos A; Izzo L; Bolognese A
    J Exp Clin Cancer Res; 2002 Jun; 21(2):229-32. PubMed ID: 12148583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
    Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followup.
    Haferkamp A; Bastian PJ; Jakobi H; Pritsch M; Pfitzenmaier J; Albers P; Hallscheidt P; Müller SC; Hohenfellner M
    J Urol; 2007 May; 177(5):1703-8. PubMed ID: 17437789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors for renal cell carcinoma with tumor thrombus extension.
    Klatte T; Pantuck AJ; Riggs SB; Kleid MD; Shuch B; Zomorodian N; Kabbinavar FF; Belldegrun AS
    J Urol; 2007 Oct; 178(4 Pt 1):1189-95; discussion 1195. PubMed ID: 17698087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The therapeutic value of adrenalectomy in case of solitary metastatic spread originating from primary renal cell cancer.
    Kuczyk M; Wegener G; Jonas U
    Eur Urol; 2005 Aug; 48(2):252-7. PubMed ID: 15936136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tumor size and regional lymph node metastasis in patients with M0 renal cell carcinoma: analysis in those having regional lymph node dissection].
    Hashimoto K; Hisasue S; Yanase M; Takahashi A; Hisataki T; Kitamura H; Masumori N; Itoh N; Tsukamoto T
    Hinyokika Kiyo; 2005 Sep; 51(9):621-5. PubMed ID: 16229376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients.
    Becker F; Siemer S; Humke U; Hack M; Ziegler M; Stöckle M
    Eur Urol; 2006 Feb; 49(2):308-13. PubMed ID: 16359779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas.
    Klatte T; Patard JJ; de Martino M; Bensalah K; Verhoest G; de la Taille A; Abbou CC; Allhoff EP; Carrieri G; Riggs SB; Kabbinavar FF; Belldegrun AS; Pantuck AJ
    J Urol; 2008 May; 179(5):1719-26. PubMed ID: 18343437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.
    Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1878-82. PubMed ID: 17868733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reassessing the current TNM lymph node staging for renal cell carcinoma.
    Terrone C; Cracco C; Porpiglia F; Bollito E; Scoffone C; Poggio M; Berruti A; Ragni F; Cossu M; Scarpa RM; Rossetti SR
    Eur Urol; 2006 Feb; 49(2):324-31. PubMed ID: 16386352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multi-modal treatment of primarily using continuous subcutaneous interferon-alpha injection in combination with surgery and/or radiotherapy.
    Maruoka M; Fujimura M; Kawamura K; Suzuki S; Hamano M; Nishikawa Y; Nagayama T
    Int J Urol; 2005 May; 12(5):442-8. PubMed ID: 15948742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma.
    Dall'Oglio MF; Ribeiro-Filho LA; Antunes AA; Crippa A; Nesrallah L; Gonçalves PD; Leite KR; Srougi M
    J Urol; 2007 Aug; 178(2):425-8; discussion 428. PubMed ID: 17561167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.